Ficha del valor · trimestre archivado
SRPT
Sarepta Therapeutics, Inc. · Healthcare · Biotechnology
15Tenedores rastreados
-1Δ titulares
40.14MAcciones mantenidas
$686.46MValor declarado
+1Nuevas posiciones
−2Cierres
Señales de momentum (gestores comparables):
amplitud de titulares -6.2% ·
flujo de acciones +24.2% ·
nuevas posiciones netas -6.7%
— fórmula
Acumulación concentrada — aumento de acciones entre menos titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2025
Participación a lo largo del tiempo
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 110 | +2 | 83.40M | $1.50B | +14 | −12 |
| Q1 2026 | 111 | +1 | 76.41M | $1.66B | +6 | −6 |
| Q4 2025 | 110 | +2 | 75.97M | $1.63B | +3 | — |
| Q3 2025 | 17 | 0 | 44.07M | $848.49M | +2 | −3 |
| Q2 2025 | 15 | -1 | 40.14M | $686.46M | +1 | −2 |
| Q1 2025 | 13 | -1 | 11.03M | $703.96M | +1 | −2 |
| Q4 2024 | 14 | -1 | 10.27M | $1.25B | +2 | −3 |
| Q3 2024 | 14 | +1 | 7.65M | $955.24M | +1 | — |
| Q2 2024 | 13 | — | 7.85M | $1.24B | — | — |
Quién lo tiene en cartera · Q2 2025
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasivo) | 12.12M | — | $207.17M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (pasivo) | 12.12M | — | $207.17M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (pasivo) | 12.12M | — | $207.17M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (pasivo) | 12.12M | — | $207.17M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (pasivo) | 12.12M | — | $207.17M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (pasivo) | 12.12M | — | $207.17M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (pasivo) | 12.12M | — | $207.17M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (pasivo) | 12.12M | — | $207.17M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (pasivo) | 12.12M | — | $207.17M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (pasivo) | 12.12M | — | $207.17M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (pasivo) | 12.12M | — | $207.17M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (pasivo) | 12.12M | — | $207.17M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (pasivo) | 12.12M | — | $207.17M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (pasivo) | 12.12M | — | $207.17M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (pasivo) | 12.12M | — | $207.17M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (pasivo) | 12.12M | — | $207.17M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (pasivo) | 12.12M | — | $207.17M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | BlackRock ✦ (pasivo) | 12.12M | — | $207.17M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | The Vanguard Group ✦ (pasivo) | 9.16M | — | $156.64M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | The Vanguard Group ✦ (pasivo) | 9.16M | — | $156.64M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | The Vanguard Group ✦ (pasivo) | 9.16M | — | $156.64M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | The Vanguard Group ✦ (pasivo) | 9.16M | — | $156.64M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | The Vanguard Group ✦ (pasivo) | 9.16M | — | $156.64M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | State Street Global Advisors ✦ (pasivo) | 4.70M | +15.4% | $80.28M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 25 | D. E. Shaw & Co. ✦ | 4.48M | +101548.6% | $76.58M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 26 | D. E. Shaw & Co. ✦ | 4.48M | +101548.6% | $76.58M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 27 | Wellington Management ✦ | 2.53M | -4.4% | $43.27M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 28 | Wellington Management ✦ | 2.53M | -4.4% | $43.27M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 29 | Wellington Management ✦ | 2.53M | -4.4% | $43.27M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 30 | Wellington Management ✦ | 2.53M | -4.4% | $43.27M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 31 | Wellington Management ✦ | 2.53M | -4.4% | $43.27M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 32 | Two Sigma Investments ✦ | 2.16M | +292.4% | $36.97M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 33 | Geode Capital Management ✦ (pasivo) | 1.88M | +3.0% | $32.08M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 34 | Geode Capital Management ✦ (pasivo) | 1.88M | +3.0% | $32.08M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 35 | Millennium Management ✦ | 1.06M | +413.3% | $18.16M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 36 | Norges Bank ✦ (pasivo) | 913.41K | -23.4% | $15.62M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 37 | Renaissance Technologies ✦ | 624.48K | Nuevo | $10.68M | 0.0% | New | 1 | SEC ↗ |
| 38 | Citadel Advisors ✦ | 302.16K | +28.1% | $5.17M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 39 | AQR Capital Management ✦ | 125.98K | +2239.4% | $2.15M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 40 | AQR Capital Management ✦ | 125.98K | +2239.4% | $2.15M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 41 | AQR Capital Management ✦ | 125.98K | +2239.4% | $2.15M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 42 | T. Rowe Price ✦ | 76.78K | -67.8% | $1.31M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 43 | T. Rowe Price ✦ | 76.78K | -67.8% | $1.31M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 44 | Fisher Asset Management ✦ | 12.91K | +1.2% | $220,761 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 45 | Fidelity (FMR) ✦ | 8.20K | — | $140,137 | 0.0% | n/c | 1 | SEC ↗ |
| 46 | Fidelity (FMR) ✦ | 8.20K | — | $140,137 | 0.0% | n/c | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Renaissance Technologies | $10.68M | 0.0% |
Posición cerrada
| Marshall Wace | $1.74M | era 0.0% |
| Bridgewater Associates | $1.26M | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 339 tenedores, 102.41M acciones, $2.16B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Frecuentemente cotituladas
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Procedencia: Participación a partir de posiciones en acciones ordinarias de 13F procesadas (universo rastreado, conjuntos comparables para cambios); filas de iniciados de los Formularios 3/4/5; participaciones de los Schedules 13D/13G; cada filing enlaza con su original en SEC EDGAR.
Período de reporte: Q2 2025 ·
Metodología ·
Obtener esto a través de la API